![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of Pharmacokinetic (PK) Interaction Between Rilpivirine and the Integrase Inhibitors Dolutegravir and S/GSK1265744
|
|
|
Reported by Jules Levin
52nd ICAAC Sept 9-12 2012 SF
Susan L. Ford,1 Elizabeth Gould,1 Shuguang Chen,1 David Margolis,1 William Spreen,1 Herta Crauwels,2 Steve Piscitelli1
1GlaxoSmithKline, Research Triangle Park, NC, United States; 2Janssen R&D, Beerse, Belgium
![IAAC1.gif](../images/091212/091212-3/IAAC1.gif)
![IAAC2.gif](../images/091212/091212-3/IAAC2.gif)
![IAAC3.gif](../images/091212/091212-3/IAAC3.gif)
![IAAC4.gif](../images/091212/091212-3/IAAC4.gif)
![IAAC5.gif](../images/091212/091212-3/IAAC5.gif)
![IAAC6.gif](../images/091212/091212-3/IAAC6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|